UAB "Solita" implements the project "Development of UAB "Solita" export markets through participation in exhibitions" no. 02-036-K-0041. The total value of the project is 193 422.00 EUR, of which 96 711.00 EUR are European Union funds.

The project is implemented in accordance with the Agreement, development program progress measure no. 05-001-01-11-04 "Implementing measures promoting the growth of export competitiveness" in the description of the activity "Promoting the internationalization of SME activities and identification of new export markets (Central and Western Lithuania region)", approved by the Minister of Economy and Innovation of the Republic of Lithuania in 2023. August 9 by order no. 4-438 "On the Decree of the Minister of Economy and Innovation in 2022 August 2 order no. 4-895 "Regarding the 2022-2023 development program manager of the Ministry of Economy and Innovation of the Republic of Lithuania, Economic Transformation and Competitiveness Development Program Progress Measure No. 05-001-01-11-04 description approval" (with the latest amendments), in the project administration and financing rules, approved by the Minister of Finance of the Republic of Lithuania in 2022. June 22 by order no. 1K-237 "On the implementation of the 2021-2027 European Union Funds Investment Program and the Economic Revitalization and Resilience Enhancement Plan "New Generation Lithuania", and the conditions and procedures set forth in the legal acts of the EU and the Republic of Lithuania referred to in them.

The activities of the project are aimed at promoting the export of UAB "Solita" products, searching for new export markets and developing existing markets, increasing the company's competitiveness. Investments are planned for the presentation of SMEs and their products at international exhibitions held abroad.

UAB "Solita" works in the information technology market and operates in the field of development, maintenance and support of IT systems and websites.

Since the company has occupied a considerable share of the Lithuanian market, it is trying to increase the company's turnover by looking for foreign markets, the first steps have already been taken, the company has started export activities, but in order to expand exports on a larger scale, it is necessary to present its products in detail at exhibitions, and this requires significant investments. The company does not have the ability to implement the project with its own funds, so an external source of support is needed, as there is an untapped opportunity to carry out export development. The goal of the project is to ensure the emergence of new export markets, thereby contributing to the diversification of the company's markets and risks, increase in turnover, export, competitiveness and overall growth of Lithuanian export volumes.

It is planned that participation in international exhibitions related to the company's services will help to find potential customers and partners in foreign countries who will appreciate the quality of UAB "Solita" services and the long-term experience. Currently, the company already exports its services, but it seeks to better utilize its potential, and therefore intends to expand exports by participating in exhibitions. Interest from foreign countries is already noticeable. The exhibitions were chosen taking into account the fact that these are countries with a high level of technological development and huge development potential in the sector operated by the company. By establishing the necessary contacts in these markets in time, one can expect to occupy a significant market share.

The project implementation period is 2024. June 4 - in 2026 October month. on the 31st

Inquiries related to the project can be addressed to info@solita.lt

Solita UAB implements the project "Creation of the MetaEndo diagnostic system" no. 02-020-K-0022. The total value of the project is 625 756.72 EUR, of which 420 025.97 EUR is the European Regional Development Fund.

The project is implemented in accordance with the Agreement, development program progress measure no. 05-001-01-05-07 "Create a coherent system for the promotion of innovative activities" the effects of the activity "Promote the supply of innovations" "Invest in the development of new APV products and provide opportunities for researchers to participate in the R&D activities of companies, promote intellectual property, early testing of new products created production, preparation for the market" (Central and Western Lithuania region) in the description of project financing conditions, approved by the Minister of Economy and Innovation of the Republic of Lithuania in 2023. July 7 by order no. 4-368, in the project administration and financing rules, approved by the Minister of Finance of the Republic of Lithuania in 2022. June 22 by order no. 1K-237 "On the implementation of the 2021-2027 European Union Funds Investment Program and the Economic Revitalization and Resilience Enhancement Plan "New Generation Lithuania", and the conditions and procedures set forth in the legal acts of the EU and the Republic of Lithuania referred to in them.

According to the World Health Organization, about one in six couples or about 180 million people in the world face the problem of infertility. Assisted fertilization, in which developing embryos created in a laboratory from human gametes are placed in a woman's uterus, is often the only way couples with fertility problems can become parents. In the world, more than 1.5 million cycles of assisted reproduction treatment are performed per year, after which more than 350 thousand are born every year. newborns, but less than a third of couples have a baby after assisted fertilization. The success of the procedure depends on many reasons: the quality of the germ cells - eggs and sperm - which is often determined by the age of the couple, the viability of early-stage embryos and blastocysts, genomic mutations of the embryo, the receptivity of the uterine lining and other circumstances. The market needs a complex assessment system that combines the results of all possible studies and is able to increase the efficiency of IVF. Such a digital solution, based on medical knowledge and artificial intelligence technologies, is planned to be created by high-tech companies in cooperation with the Lithuanian University of Health Sciences.

The applicant of the project, UAB "Solita" - an information technology company, since 2018. developing digital solutions for clients of all sizes and industry sectors, conducting scientific, experimental and technological development research, creating innovative products.

Project partner "Power of Eye" UAB is a high-tech company founded in 2012 that successfully develops, produces, and distributes dedicated computer vision algorithms. Their know-how in developing various algorithms enables business expansion and offering feature extraction methods from histological images with result visualization.

Project partner Lithuanian University of Health Sciences (LSMU) is an academic institution with extensive research and experimental development experience. LSMU focuses on innovative scientific knowledge and competency development through independent high-level research and technological advancement. LSMU Reproductive Medicine Center scientists and specialists will join as partners for the project's research needs.

These three highly competent partners aim to create a unique, research-based solution supported by AI and machine learning methods. This solution integrates clinical, molecular, transcriptomic, immunological, and hormonal markers with automated (AI-based) endometrial tissue histological assessment to improve IVF process management. The MetaEndo multi-diagnostic system is a new individualized healthcare service that will significantly improve IVF efficiency, cost-effectiveness, success rates, and reduce treatment duration. MetaEndo will use deep neural networks (DNN) and automated decision-making algorithms to link digital endometrial biopsy histological images with specific histological features and individual patient characteristics. MetaEndo will help better understand uterine mucosa functional layer structure, morphology, cellular interactions, and correctly interpret the limited optimal receptivity or implantation window time.

MetaEndo will help fertility clinics improve diagnostics and IVF process efficiency, better allocate human and financial resources, increase service cost-effectiveness, and apply more consistent treatment. The MetaEndo system will significantly impact medical science by enabling advanced diagnostics, allowing researchers and clinical groups to share knowledge and utilize AI methods.

Project implementation period: June 11, 2024 - June 11, 2026.

Inquiries related to the project can be addressed to info@solita.lt

UAB “Solita” is implementing the EU-funded project No 13.1.1-LVPA-K-310-01-0267 "Digitisation of software development ordering process". The total value of the project is 90 200,00 EUR, of which 43 296,00 EUR is from the European Regional Development Fund.

The support for the implementation of the project was granted under Priority 13 of the Operational Programme for Investment of European Union Funds 2014-2020 "Promoting actions to overcome the crisis caused by the COVID-19 pandemic and preparing for an environmentally friendly, digital and sustainable economic recovery", Measure No. 13.1.1-LVPA-K-310 "Incentives for the cultural and creative industries to develop competitive cultural products". The project is funded by the European Regional Development Fund. It is funded as part of the European Union's response to the COVID-19 pandemic.

The project aims to develop new, high added value, competitive cultural and creative content and form products by investing in a new competitive digital cultural and creative content and form product. The company aims to digitise IT outsourcing services, i.e. to move services from a physical environment to a digital platform that is user-friendly and accessible in an online environment.

The project will create a digital platform for the management and deployment of the information technology (IT) service ordering process within the company's infrastructure. The digitalisation of the company's IT service delivery process will increase the availability of IT services to the customer and open up access to control over the performance of services. The platform will facilitate the ordering of IT services for customers, bring more clarity and transparency and allow customers and developers to plan their time rationally. The digital platform will simplify the way of ordering the service, provide direct access to a team of specialists and the possibility to monitor the progress of the IT service, evaluate the service provided, and enable the service provider to respond in real time and in a timely manner to customer queries. This digital solution will help the company to manage its processes smoothly, serve customers promptly, save resources, take more orders and increase revenue.

The project will run from July 2022 to March 2023.